JP2022521787A5 - - Google Patents
Info
- Publication number
- JP2022521787A5 JP2022521787A5 JP2021549970A JP2021549970A JP2022521787A5 JP 2022521787 A5 JP2022521787 A5 JP 2022521787A5 JP 2021549970 A JP2021549970 A JP 2021549970A JP 2021549970 A JP2021549970 A JP 2021549970A JP 2022521787 A5 JP2022521787 A5 JP 2022521787A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- cells
- donor dna
- nucleotides
- population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024219750A JP2025061660A (ja) | 2018-02-27 | 2024-12-16 | Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862635702P | 2018-02-27 | 2018-02-27 | |
| US16/288,052 | 2019-02-27 | ||
| US16/288,052 US20200224160A1 (en) | 2018-02-27 | 2019-02-27 | Process for dna integration using rna-guided endonucleases |
| PCT/US2020/020121 WO2020176740A1 (en) | 2018-02-27 | 2020-02-27 | Improved process for dna integration using rna-guided endonucleases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024219750A Division JP2025061660A (ja) | 2018-02-27 | 2024-12-16 | Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521787A JP2022521787A (ja) | 2022-04-12 |
| JP2022521787A5 true JP2022521787A5 (enExample) | 2023-03-07 |
Family
ID=71516309
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549970A Ceased JP2022521787A (ja) | 2018-02-27 | 2020-02-27 | Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法 |
| JP2024219750A Pending JP2025061660A (ja) | 2018-02-27 | 2024-12-16 | Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024219750A Pending JP2025061660A (ja) | 2018-02-27 | 2024-12-16 | Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20200224160A1 (enExample) |
| EP (1) | EP3931322A1 (enExample) |
| JP (2) | JP2022521787A (enExample) |
| KR (1) | KR20210134000A (enExample) |
| CN (1) | CN113906136A (enExample) |
| AU (1) | AU2020229848A1 (enExample) |
| CA (1) | CA3131588A1 (enExample) |
| IL (1) | IL285842A (enExample) |
| MX (1) | MX2021010322A (enExample) |
| SG (1) | SG11202109332RA (enExample) |
| WO (1) | WO2020176740A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015330699B2 (en) | 2014-10-10 | 2021-12-02 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| WO2019165168A1 (en) | 2018-02-23 | 2019-08-29 | Pioneer Hi-Bred International, Inc. | Novel cas9 orthologs |
| WO2020123887A2 (en) | 2018-12-14 | 2020-06-18 | Pioneer Hi-Bred International, Inc. | Novel crispr-cas systems for genome editing |
| KR20210133261A (ko) * | 2019-02-26 | 2021-11-05 | 소렌토 쎄라퓨틱스, 인코포레이티드 | Bcma에 결합하는 항원 결합 단백질 |
| EP3773918A4 (en) | 2019-03-05 | 2022-01-05 | Nkarta, Inc. | CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY |
| EP3980533A1 (en) | 2019-06-07 | 2022-04-13 | Scribe Therapeutics Inc. | Engineered casx systems |
| EP4139345A1 (en) | 2020-04-24 | 2023-03-01 | Sorrento Therapeutics, Inc. | Memory dimeric antigen receptors |
| WO2022015956A1 (en) | 2020-07-15 | 2022-01-20 | Sorrento Therapeutics, Inc. | Improved process for dna integration using rna-guided endonucleases |
| AU2021320556A1 (en) * | 2020-08-07 | 2023-03-09 | Neogene Therapeutics B.V. | Methods to enrich genetically engineered T cells |
| JP2023550323A (ja) | 2020-11-11 | 2023-12-01 | モンサント テクノロジー エルエルシー | 部位特異的組込み頻度を改善するための方法 |
| KR20230128289A (ko) | 2020-12-03 | 2023-09-04 | 스크라이브 테라퓨틱스 인크. | 조작된 클래스 2 유형 v crispr 시스템 |
| WO2022215978A1 (ko) * | 2021-04-05 | 2022-10-13 | 주식회사 셀렌진 | Pdcd-1 유전자에 상보적인 가이드 rna 및 이의 용도 |
| WO2026020171A2 (en) | 2024-07-19 | 2026-01-22 | Aera Therapeutics, Inc. | Chimeric antigen receptor constructs |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6010907A (en) * | 1998-05-12 | 2000-01-04 | Kimeragen, Inc. | Eukaryotic use of non-chimeric mutational vectors |
| US6556674B1 (en) | 1998-11-19 | 2003-04-29 | Legerity, Inc. | Signal detector with matched filter coefficient |
| US9957515B2 (en) * | 2013-03-15 | 2018-05-01 | Cibus Us Llc | Methods and compositions for targeted gene modification |
| WO2014191128A1 (en) * | 2013-05-29 | 2014-12-04 | Cellectis | Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system |
| WO2017070429A1 (en) * | 2015-10-22 | 2017-04-27 | Regents Of The University Of Minnesota | Methods involving editing polynucleotides that encode t cell receptor |
| EP4628587A3 (en) * | 2016-04-15 | 2026-02-25 | Memorial Sloan Kettering Cancer Center | Transgenic t cell and chimeric antigen receptor t cell compositions and related methods |
| US10428327B2 (en) * | 2016-05-27 | 2019-10-01 | Life Technologies Corporation | Compositions and methods for enhancing homologous recombination |
| WO2018023631A1 (zh) * | 2016-08-04 | 2018-02-08 | 汤隆初 | 自动浇水技术的使用情况反馈方法以及自动浇水装置 |
| WO2018073391A1 (en) * | 2016-10-19 | 2018-04-26 | Cellectis | Targeted gene insertion for improved immune cells therapy |
| EP3679144A1 (en) * | 2017-09-08 | 2020-07-15 | Life Technologies Corporation | Methods for improved homologous recombination and compositions thereof |
| EP3781677A4 (en) * | 2018-04-16 | 2022-01-19 | University of Massachusetts | COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITTING |
-
2019
- 2019-02-27 US US16/288,052 patent/US20200224160A1/en not_active Abandoned
-
2020
- 2020-02-27 WO PCT/US2020/020121 patent/WO2020176740A1/en not_active Ceased
- 2020-02-27 EP EP20715999.7A patent/EP3931322A1/en not_active Withdrawn
- 2020-02-27 JP JP2021549970A patent/JP2022521787A/ja not_active Ceased
- 2020-02-27 MX MX2021010322A patent/MX2021010322A/es unknown
- 2020-02-27 CN CN202080031829.1A patent/CN113906136A/zh active Pending
- 2020-02-27 CA CA3131588A patent/CA3131588A1/en active Pending
- 2020-02-27 AU AU2020229848A patent/AU2020229848A1/en not_active Abandoned
- 2020-02-27 SG SG11202109332RA patent/SG11202109332RA/en unknown
- 2020-02-27 US US17/434,209 patent/US20220169984A1/en active Pending
- 2020-02-27 KR KR1020217030805A patent/KR20210134000A/ko not_active Withdrawn
-
2021
- 2021-08-24 IL IL285842A patent/IL285842A/en unknown
-
2024
- 2024-12-16 JP JP2024219750A patent/JP2025061660A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022521787A5 (enExample) | ||
| JP7579820B2 (ja) | 化学修飾を有するガイドｒｎａ | |
| JP7038079B2 (ja) | Ｃｒｉｓｐｒハイブリッドｄｎａ／ｒｎａポリヌクレオチドおよび使用方法 | |
| KR102738283B1 (ko) | 암 면역요법을 위한 crispr-cpf1-관련 방법, 조성물 및 구성성분 | |
| ES2884838T3 (es) | ARN guía químicamente modificados para la regulación génica mediada por CRISPR/CAS | |
| US10526590B2 (en) | Compounds and methods for CRISPR/Cas-based genome editing by homologous recombination | |
| AU2024259841A1 (en) | CRISPR-Cas-related methods, compositions and components for cancer immunotherapy | |
| JP2022137068A (ja) | 化学的に修飾されたガイドｒｎａを使用する高特異性ゲノム編集 | |
| EP3464323B1 (en) | Peptides and nanoparticles for intracellular delivery of genome-editing molecules | |
| AU2020201465A1 (en) | Using truncated guide rnas (tru-grnas) to increase specificity for rna-guided genome editing | |
| JP2022524435A5 (enExample) | ||
| WO2016161380A1 (en) | Crispr/cas-related methods and compositions for treating duchenne muscular dystrophy and becker muscular dystrophy | |
| EP4399294A1 (en) | Guide rnas with chemical modification for prime editing | |
| US20250257342A1 (en) | Peptides and nanoparticles for intracellular delivery of genome-editing molecules | |
| RU2020100919A (ru) | СПОСОБ НОКАУТИРОВАНИЯ ГЕНА-МИШЕНИ В T-КЛЕТКЕ IN VITRO И crRNA, ПРИМЕНЯЕМАЯ В ДАННОМ СПОСОБЕ | |
| JP2024533448A (ja) | 化学修飾を有するガイドｒｎａを使用する方法 | |
| CA3253302A1 (en) | CELL COMPOSITIONS AND ENGINEERING METHODS | |
| HK40064529A (en) | Peptides and nanoparticles for intracellular delivery of genome-editing molecules | |
| CA3230928A1 (en) | Methods for using guide rnas with chemical modifications | |
| HK40006957B (en) | Peptides and nanoparticles for intracellular delivery of genome-editing molecules |